From: Projecting productivity losses for cancer-related mortality 2011 – 2030
Cancer | Total lost household productivity (base case) | Total lost household productivity (opportunity cost) | % of base case |
---|---|---|---|
(Million €) | (Million €) | % | |
C01-C14: mouth & pharynx | €954 | €975 | 102 |
C15: oesophagus | €2322 | €2067 | 89 |
C16: stomach | €2265 | €1824 | 81 |
C18-C21: colorectal | €6567 | €4571 | 70 |
C22: liver | €1682 | €1330 | 79 |
C25: pancreas | €3355 | €2392 | 71 |
C34: lung | €12,493 | €8730 | 70 |
C43: melanoma skin | €1109 | €1096 | 99 |
C44: non-melanoma skin | €492 | €374 | 76 |
C50: breast | €7194 | €3444 | 48 |
C53: cervix | €1218 | €763 | 63 |
C54: corpus uteri | €706 | €239 | 34 |
C56: ovary | €2626 | €987 | 38 |
C61: prostate | €2794 | €1911 | 68 |
C62: testis | €81 | €175 | 217 |
C64: kidney | €1374 | €1228 | 89 |
C67: bladder | €1240 | €830 | 67 |
C70-C72: brain and CNS | €2164 | €2129 | 98 |
C81-C85: lymphoma (total) | €1989 | €1483 | 75 |
C90: multiple myeloma | €1032 | €670 | 65 |
C91-C95: leukaemia (total) | €1691 | €1267 | 75 |
Other invasive cancers bar specified | €6282 | €4286 | 68 |
C00-C96: all invasive cancer deaths | €60,427 | €41,286 | 68 |